Filtered By:
Therapy: Immunotherapy

This page shows you your search results in order of date.

Order by Relevance | Date

Total 6127 results found since Jan 2013.

Phenotypic changes in mast cells during allergy immunotherapy
Arerugi. 2023;72(8):1026-1031. doi: 10.15036/arerugi.72.1026.NO ABSTRACTPMID:37730345 | DOI:10.15036/arerugi.72.1026
Source: Allergology International - September 20, 2023 Category: Allergy & Immunology Authors: Haruki Sasa Hitoshi Ogata Yosuke Kurashima Source Type: research

Phenotypic changes in mast cells during allergy immunotherapy
Arerugi. 2023;72(8):1026-1031. doi: 10.15036/arerugi.72.1026.NO ABSTRACTPMID:37730345 | DOI:10.15036/arerugi.72.1026
Source: Arerugi - September 20, 2023 Category: Allergy & Immunology Authors: Haruki Sasa Hitoshi Ogata Yosuke Kurashima Source Type: research

Phenotypic changes in mast cells during allergy immunotherapy
Arerugi. 2023;72(8):1026-1031. doi: 10.15036/arerugi.72.1026.NO ABSTRACTPMID:37730345 | DOI:10.15036/arerugi.72.1026
Source: Allergology International - September 20, 2023 Category: Allergy & Immunology Authors: Haruki Sasa Hitoshi Ogata Yosuke Kurashima Source Type: research

The Role of IgA in the Manifestation and Prevention of Allergic Immune Responses
AbstractPurpose of ReviewImmunoglobulin A (IgA) mediates immune exclusion of antigens in the gut. Notably, IgA plays also a role in the prevention of IgE-mediated allergies and induction of immune tolerance. The present review addresses the role of IgA in the manifestation of IgE-mediated allergies, including allergen-specific immunotherapy (AIT), the regulation of IgA production, and the mechanism of IgA in immune cell activation.Recent FindingsThe majority of studies report an association of IgA with the induction of immune tolerance in IgE-mediated allergies. However, reports on the involvement of humoral and mucosal Ig...
Source: Current Allergy and Asthma Reports - September 19, 2023 Category: Allergy & Immunology Source Type: research

Occupational Rhinitis: An Update
Discussion includes the impact of social trends on workers and the wider consequences of occupational rhinitis including decreased work productivity, absenteeism, and socioeconomic burden.SummaryOccupational rhinitis remains a challenging disease entity due to the numerous potential causative factors, reduced recognition, morbidity in asthma, and therapeutic limitations. Additional research is needed to better identify disease predictors and develop effective management strategies.
Source: Current Allergy and Asthma Reports - September 19, 2023 Category: Allergy & Immunology Source Type: research

Combination of omalizumab with allergen immunotherapy versus immunotherapy alone for allergic diseases: A meta ‐analysis of randomized controlled trials
ConclusionOmalizumab + AIT can significantly enhance the efficacy and safety of AIT by increasing TMD and SU to allergens, while decreasing severe systemic AEs.
Source: International Forum of Allergy and Rhinology - September 16, 2023 Category: Allergy & Immunology Authors: Ying ‐Ying Zhang, Min Zhang, Jia‐Qi Zhang, Qiu‐Qi Li, Mei‐Ping Lu, Lei Cheng Tags: ORIGINAL ARTICLE Source Type: research

Molecular profiling of allergen-antibody IgE might decide about the efficacy of allergen immunotherapy in a patient with atopic dermatitis and allergy to house dust mites
CONCLUSIONS: HDM AIT could be helpful for patients with moderate-to-severe AD and sensitised to HDM as an add-on therapy. Various HDM molecules may affect the effectiveness of the expected AIT.PMID:37692262 | PMC:PMC10485758 | DOI:10.5114/ada.2023.129456
Source: Advances in Dermatology and Allergology - September 11, 2023 Category: Dermatology Authors: Agnieszka Bogacz-Piaseczy ńska Andrzej Bo żek Maciej Pastuszczak Jolanta Zalejska-Fiolka Source Type: research